pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Hiroshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Subject who is histologically confirmed pancreatic cancer. 2)Subject whose agreement with signiture of aplicant has obtained before initiation of this study.
Exclusion criteria
Exclusion criteria: 1)Subjects who have another malignancies simultaneously. 2)Subjects who is participating in another clinical trial affect to primary or secondary end-point of this study 3)Subjects whose Hb levels were less than 7 g/dL 4)Subject who is judged to be ineligible due to subject's background, physical findings, medical examination, physical and clinical examination by principal investigator or sub investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of the detectable curculating tumor DNA for prognostic factor of pancreatic caner patients. | — |
Countries
Japan
Contacts
Public ContactNaoto Hadano
Hiroshima University Institute of Biomedical and Health Sciences Applied Life Sciences Surgery
Outcome results
None listed